Dr. Marc Rendell is a board-certified physician in Internal Medicine and in Endocrinology and Metabolism.. His medical career began after earning a B.S., Magna Cum Laude, from CUNY in 1968, followed by his M.D., Cum Laude, from the SUNY Downstate Medical Center in 1972. He completed his internal medicine residency training at Lenox Hill Hospital and the University of Connecticut Medical School. He the spent two years as a Research Associate at the National Cancer Institute and worked with Dr. Martin Rodbell who subsequently received a Nobel Prize.. He then did a Fellowship in Endocrinology at the University of Miami Medical Center and was recruited to The Johns Hopkins University School of Medicine by Dr. Victor McKusick. He served as Assistant Professor of Medicine and Chief of Endocrinology, Director of the Radioimmunoassay Laboratory, and Director of the Clinical Investigations Unit at the USPHS Hospital in Baltimore, Maryland from 1977 to 1983..
In 1983, he relocated to Tulsa, Oklahoma, to serve as Director of the Diabetes Institute and Associate Professor of Medicine and Pathology at the City of Faith Medical and Research Center and the ORU School of Medicine.
In February 1985, Dr. Rendell became the Director of the Creighton Diabetes Center in Omaha, Nebraska, a role he held until September 2016. During his long tenure at the Creighton University School of Medicine, he advanced through the academic ranks, ultimately serving as Professor of Medicine and Biomedical Sciences from 1996 to 2016. Throughout his career, he has additionally contributed to his field by serving on the Board of Editors for the Journal of Clinical Endocrinology and Metabolism and on advisory committees for the FDA. He is currently Academic Editor for the endocrinology section of Annals of Medicine and Associate Editor of Diabetology.
Dr. Rendell currently holds several prominent leadership roles. Since 1999, he has served as Medical Director of the Rose Salter Medical Research Foundation, and in 2000, he became Executive Director of the Association of Diabetes Investigators. In September 2016, he assumed the role of Medical Director at the Rose Salter Diabetes Center in Newport Beach, California. He early on practiced Telemedicine on various platforms including the Veterans Hospital system, Amwell, and MDLIVE.
He is a Qualified Medical Examiner in California.